08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
What can we learn from past contracts, good and bad, and how they played out in the courtroom? In th...
Read More >
This case arises out of a dispute over a provision of a collective bargaining agreement entered into...
Read More >
On October 17, 2019, the Florida First District Court of Appeal addressed whether the Judge of Compe...
Read More >
I just blogged about asking for what you want and the importance of complying with notice provisions...
Read More >
Freddie Mac and Fannie Mae recently announced, in response to the COVID-19 crisis, a new adverse mar...
Read More >
The global M&A market staged a remarkable recovery in the second half of last year, despite an escal...
Read More >